Sabra Healthcare REIT (NASDAQ:SBRA) Shares Break Above Two Hundred Day Moving Average Following Weak Earnings

Shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) crossed above its 200-day moving average during trading on Tuesday following a better than expected earnings announcement. The stock has a 200-day moving average of $19.97 and traded as high as $20.39. Sabra Healthcare REIT shares last traded at $20.35, with a volume of 4,574,479 shares trading hands.

The real estate investment trust reported $0.11 EPS for the quarter, missing analysts’ consensus estimates of $0.16 by ($0.05). The business had revenue of $249.57 million for the quarter, compared to the consensus estimate of $236.64 million. Sabra Healthcare REIT had a return on equity of 2.56% and a net margin of 7.78%. The business’s revenue was up 31.4% compared to the same quarter last year. During the same quarter last year, the business posted $0.38 earnings per share.

Sabra Healthcare REIT Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, November 30th. Shareholders of record on Friday, November 13th will be issued a dividend of $0.30 per share. The ex-dividend date of this dividend is Friday, November 13th. This represents a $1.20 dividend on an annualized basis and a yield of 5.9%. Sabra Healthcare REIT’s payout ratio is presently 461.54%.

Key Stories Impacting Sabra Healthcare REIT

Here are the key news stories impacting Sabra Healthcare REIT this week:

• Positive Sentiment: Sabra raised its 2026 EPS guidance to $1.54–$1.55, above the prior analyst consensus of $1.52. Management also expects 7%–8% year-over-year earnings growth in 2026. Read More.
• Positive Sentiment: Third-quarter revenue rose 31.4% year over year to about $249.6 million, topping the roughly $236.6 million analyst estimate. A report also said quarterly FFO of $0.41 per share beat the $0.40 consensus. Read More.
• Positive Sentiment: Sabra is targeting 50% exposure to its senior housing operating portfolio (SHOP) by the end of 2027. Its CEO pointed to asset optimization and lease negotiations as additional sources of potential upside. Read More. · Read More.
• Positive Sentiment: The REIT declared a quarterly dividend of $0.30 per share, equivalent to $1.20 annually and a reported yield of 6%. Read More.
• Negative Sentiment: Reported third-quarter EPS was $0.11, below the $0.16 consensus and down from $0.38 a year earlier. This earnings shortfall tempers the stronger revenue and outlook news. Read More.

Wall Street Analyst Weigh In

A number of research firms have recently commented on SBRA. Mizuho set a $21.00 price target on shares of Sabra Healthcare REIT in a research report on Monday, August 31st. Barclays dropped their target price on shares of Sabra Healthcare REIT from $23.00 to $21.00 and set an “equal weight” rating for the company in a research report on Tuesday, October 13th. Wells Fargo & Company decreased their price target on shares of Sabra Healthcare REIT from $23.00 to $21.00 and set an “overweight” rating on the stock in a report on Monday, October 19th. Citizens Jmp raised their price objective on shares of Sabra Healthcare REIT from $23.00 to $25.00 and gave the company a “market outperform” rating in a research report on Wednesday, July 22nd. Finally, Deutsche Bank Aktiengesellschaft reiterated a “buy” rating on shares of Sabra Healthcare REIT in a research report on Wednesday, July 22nd. Seven equities research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $21.50.

Insider Activity at Sabra Healthcare REIT

In other news, CEO Richard Matros sold 200,000 shares of Sabra Healthcare REIT stock in a transaction dated Tuesday, September 8th. The shares were sold at an average price of $20.83, for a total transaction of $4,166,000.00. Following the sale, the chief executive officer owned 1,657,686 shares of the company’s stock, valued at approximately $34,529,599.38. The trade was a 10.77% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 1.09% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the company. Sumitomo Mitsui Trust Group Inc. increased its stake in shares of Sabra Healthcare REIT by 6.8% during the first quarter. Sumitomo Mitsui Trust Group Inc. now owns 3,208,600 shares of the real estate investment trust’s stock valued at $61,701,000 after purchasing an additional 203,226 shares in the last quarter. Dimensional Fund Advisors LP grew its stake in shares of Sabra Healthcare REIT by 7.8% in the 1st quarter. Dimensional Fund Advisors LP now owns 3,725,337 shares of the real estate investment trust’s stock worth $71,640,000 after buying an additional 269,793 shares during the last quarter. Readystate Asset Management LP purchased a new stake in shares of Sabra Healthcare REIT in the 2nd quarter worth approximately $1,400,000. Entropy Technologies LP increased its position in Sabra Healthcare REIT by 299.6% during the 1st quarter. Entropy Technologies LP now owns 124,068 shares of the real estate investment trust’s stock valued at $2,386,000 after buying an additional 93,021 shares in the last quarter. Finally, Quantinno Capital Management LP raised its stake in Sabra Healthcare REIT by 424.3% during the first quarter. Quantinno Capital Management LP now owns 155,086 shares of the real estate investment trust’s stock valued at $2,982,000 after buying an additional 125,507 shares during the last quarter. Institutional investors own 99.40% of the company’s stock.

Sabra Healthcare REIT Stock Up 3.2%

The company has a debt-to-equity ratio of 0.95, a current ratio of 3.07 and a quick ratio of 3.07. The stock has a 50 day simple moving average of $19.85 and a 200-day simple moving average of $19.97. The firm has a market cap of $5.20 billion, a PE ratio of 72.68, a PEG ratio of 1.79 and a beta of 0.68.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc is a self-managed real estate investment trust that owns and invests in healthcare-related real estate. The company focuses primarily on properties used for skilled nursing and transitional care, senior housing, behavioral health, specialty hospitals and other healthcare services.

Sabra leases properties to healthcare operators and also provides capital through loans, joint ventures and other real estate investments. Its portfolio is designed to support a range of care settings, including facilities serving seniors, patients requiring rehabilitation and individuals receiving behavioral healthcare.

Founded in 2010 and headquartered in Irvine, California, Sabra has expanded through acquisitions, development investments and strategic transactions, including its 2017 combination with Care Capital Properties.